NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | ESRRA |
ESR2
|
ENSG00000140009.14 | ESR2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESRRA | hg19_v2_chr11_+_64073699_64073918 | 0.58 | 2.2e-01 | Click! |
ESR2 | hg19_v2_chr14_-_64804814_64804842 | 0.26 | 6.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_113735575 | 5.15 |
ENST00000376489.2 ENST00000259205.4 |
IL36G |
interleukin 36, gamma |
chr2_+_228678550 | 4.53 |
ENST00000409189.3 ENST00000358813.4 |
CCL20 |
chemokine (C-C motif) ligand 20 |
chr1_-_47655686 | 4.26 |
ENST00000294338.2 |
PDZK1IP1 |
PDZK1 interacting protein 1 |
chr5_+_131409476 | 3.16 |
ENST00000296871.2 |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
chr11_+_18154059 | 2.99 |
ENST00000531264.1 |
MRGPRX3 |
MAS-related GPR, member X3 |
chr11_-_45928830 | 2.56 |
ENST00000449465.1 |
C11orf94 |
chromosome 11 open reading frame 94 |
chr6_+_31916733 | 2.51 |
ENST00000483004.1 |
CFB |
complement factor B |
chr17_+_7533439 | 2.22 |
ENST00000441599.2 ENST00000380450.4 ENST00000416273.3 ENST00000575903.1 ENST00000576830.1 ENST00000571153.1 ENST00000575618.1 ENST00000576152.1 |
SHBG |
sex hormone-binding globulin |
chr15_+_31658349 | 2.22 |
ENST00000558844.1 |
KLF13 |
Kruppel-like factor 13 |
chr5_-_150473127 | 2.01 |
ENST00000521001.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr14_+_94577074 | 1.99 |
ENST00000444961.1 ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27 |
interferon, alpha-inducible protein 27 |
chr2_+_27282134 | 1.91 |
ENST00000441931.1 |
AGBL5 |
ATP/GTP binding protein-like 5 |
chr12_+_113416191 | 1.84 |
ENST00000342315.4 ENST00000392583.2 |
OAS2 |
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr20_-_62203808 | 1.82 |
ENST00000467148.1 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
chr19_+_7743387 | 1.82 |
ENST00000597959.1 |
CTD-3214H19.16 |
CTD-3214H19.16 |
chr14_+_24630465 | 1.80 |
ENST00000557894.1 ENST00000559284.1 ENST00000560275.1 |
IRF9 |
interferon regulatory factor 9 |
chr17_-_79304150 | 1.78 |
ENST00000574093.1 |
TMEM105 |
transmembrane protein 105 |
chr19_-_42192189 | 1.73 |
ENST00000401731.1 ENST00000338196.4 ENST00000006724.3 |
CEACAM7 |
carcinoembryonic antigen-related cell adhesion molecule 7 |
chr3_+_10206545 | 1.67 |
ENST00000256458.4 |
IRAK2 |
interleukin-1 receptor-associated kinase 2 |
chr7_-_17500294 | 1.67 |
ENST00000439046.1 |
AC019117.2 |
AC019117.2 |
chr19_-_6690723 | 1.67 |
ENST00000601008.1 |
C3 |
complement component 3 |
chr8_-_10336885 | 1.63 |
ENST00000520494.1 |
RP11-981G7.3 |
RP11-981G7.3 |
chr11_+_313503 | 1.60 |
ENST00000528780.1 ENST00000328221.5 |
IFITM1 |
interferon induced transmembrane protein 1 |
chr5_-_74348371 | 1.60 |
ENST00000503568.1 |
RP11-229C3.2 |
RP11-229C3.2 |
chr16_+_2880157 | 1.59 |
ENST00000382280.3 |
ZG16B |
zymogen granule protein 16B |
chr1_+_37947257 | 1.57 |
ENST00000471012.1 |
ZC3H12A |
zinc finger CCCH-type containing 12A |
chr11_+_66624527 | 1.57 |
ENST00000393952.3 |
LRFN4 |
leucine rich repeat and fibronectin type III domain containing 4 |
chr14_-_24729251 | 1.56 |
ENST00000559136.1 |
TGM1 |
transglutaminase 1 |
chr19_+_45251804 | 1.50 |
ENST00000164227.5 |
BCL3 |
B-cell CLL/lymphoma 3 |
chr16_+_58535372 | 1.50 |
ENST00000566656.1 ENST00000566618.1 |
NDRG4 |
NDRG family member 4 |
chr3_-_50340996 | 1.49 |
ENST00000266031.4 ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1 |
hyaluronoglucosaminidase 1 |
chr8_-_42065187 | 1.48 |
ENST00000270189.6 ENST00000352041.3 ENST00000220809.4 |
PLAT |
plasminogen activator, tissue |
chr14_+_103592636 | 1.45 |
ENST00000333007.1 |
TNFAIP2 |
tumor necrosis factor, alpha-induced protein 2 |
chr1_-_153113927 | 1.44 |
ENST00000368752.4 |
SPRR2B |
small proline-rich protein 2B |
chr1_-_153433120 | 1.43 |
ENST00000368723.3 |
S100A7 |
S100 calcium binding protein A7 |
chr20_-_34542548 | 1.43 |
ENST00000305978.2 |
SCAND1 |
SCAN domain containing 1 |
chr7_-_76955563 | 1.41 |
ENST00000441833.2 |
GSAP |
gamma-secretase activating protein |
chr14_+_103589789 | 1.41 |
ENST00000558056.1 ENST00000560869.1 |
TNFAIP2 |
tumor necrosis factor, alpha-induced protein 2 |
chr15_-_43559055 | 1.39 |
ENST00000220420.5 ENST00000349114.4 |
TGM5 |
transglutaminase 5 |
chr17_+_73750699 | 1.39 |
ENST00000584939.1 |
ITGB4 |
integrin, beta 4 |
chr1_+_152881014 | 1.39 |
ENST00000368764.3 ENST00000392667.2 |
IVL |
involucrin |
chr21_+_42792442 | 1.38 |
ENST00000398600.2 |
MX1 |
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr16_+_28857916 | 1.37 |
ENST00000563591.1 |
SH2B1 |
SH2B adaptor protein 1 |
chr2_+_113763031 | 1.37 |
ENST00000259211.6 |
IL36A |
interleukin 36, alpha |
chr19_+_45254529 | 1.36 |
ENST00000444487.1 |
BCL3 |
B-cell CLL/lymphoma 3 |
chr3_-_49726104 | 1.36 |
ENST00000383728.3 ENST00000545762.1 |
MST1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr1_-_27998689 | 1.34 |
ENST00000339145.4 ENST00000362020.4 ENST00000361157.6 |
IFI6 |
interferon, alpha-inducible protein 6 |
chr19_+_1383890 | 1.34 |
ENST00000539480.1 ENST00000313408.7 ENST00000414651.2 |
NDUFS7 |
NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) |
chr16_+_2880369 | 1.33 |
ENST00000572863.1 |
ZG16B |
zymogen granule protein 16B |
chr17_-_65992544 | 1.32 |
ENST00000580729.1 |
RP11-855A2.5 |
RP11-855A2.5 |
chr1_-_153321301 | 1.32 |
ENST00000368739.3 |
PGLYRP4 |
peptidoglycan recognition protein 4 |
chr14_+_21492331 | 1.31 |
ENST00000533984.1 ENST00000532213.2 |
AL161668.5 |
AL161668.5 |
chr16_+_3115298 | 1.31 |
ENST00000325568.5 ENST00000534507.1 |
IL32 |
interleukin 32 |
chr11_+_18287721 | 1.29 |
ENST00000356524.4 |
SAA1 |
serum amyloid A1 |
chr16_+_812506 | 1.29 |
ENST00000569566.1 |
MSLN |
mesothelin |
chr17_+_7982800 | 1.26 |
ENST00000399413.3 |
AC129492.6 |
AC129492.6 |
chr10_+_81107271 | 1.26 |
ENST00000448165.1 |
PPIF |
peptidylprolyl isomerase F |
chr12_+_122667658 | 1.25 |
ENST00000339777.4 ENST00000425921.1 |
LRRC43 |
leucine rich repeat containing 43 |
chr15_+_42565393 | 1.25 |
ENST00000561871.1 |
GANC |
glucosidase, alpha; neutral C |
chr19_+_50887585 | 1.23 |
ENST00000440232.2 ENST00000601098.1 ENST00000599857.1 ENST00000593887.1 |
POLD1 |
polymerase (DNA directed), delta 1, catalytic subunit |
chr8_-_145086922 | 1.22 |
ENST00000530478.1 |
PARP10 |
poly (ADP-ribose) polymerase family, member 10 |
chr19_+_1041212 | 1.22 |
ENST00000433129.1 |
ABCA7 |
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr11_+_118272328 | 1.20 |
ENST00000524422.1 |
ATP5L |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G |
chr16_-_2168079 | 1.18 |
ENST00000488185.2 |
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
chr19_-_6720686 | 1.18 |
ENST00000245907.6 |
C3 |
complement component 3 |
chr4_-_82965397 | 1.18 |
ENST00000512716.1 ENST00000514050.1 ENST00000512343.1 ENST00000510780.1 ENST00000508294.1 |
RASGEF1B RP11-689K5.3 |
RasGEF domain family, member 1B RP11-689K5.3 |
chr11_+_18287801 | 1.18 |
ENST00000532858.1 ENST00000405158.2 |
SAA1 |
serum amyloid A1 |
chr16_-_2827128 | 1.16 |
ENST00000494946.2 ENST00000409477.1 ENST00000572954.1 ENST00000262306.7 ENST00000409906.4 |
TCEB2 |
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) |
chr3_+_157261116 | 1.16 |
ENST00000468043.1 ENST00000459838.1 ENST00000461040.1 ENST00000449199.2 ENST00000426338.2 |
C3orf55 |
chromosome 3 open reading frame 55 |
chr6_+_33043703 | 1.16 |
ENST00000418931.2 ENST00000535465.1 |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
chrX_-_48937684 | 1.15 |
ENST00000465382.1 ENST00000423215.2 |
WDR45 |
WD repeat domain 45 |
chr1_+_149239529 | 1.15 |
ENST00000457216.2 |
RP11-403I13.4 |
RP11-403I13.4 |
chr16_+_810728 | 1.15 |
ENST00000563941.1 ENST00000545450.2 ENST00000566549.1 |
MSLN |
mesothelin |
chr12_-_102133191 | 1.14 |
ENST00000392924.1 ENST00000266743.2 ENST00000392927.3 |
SYCP3 |
synaptonemal complex protein 3 |
chr19_+_54372877 | 1.13 |
ENST00000414489.1 |
MYADM |
myeloid-associated differentiation marker |
chr14_-_103989033 | 1.12 |
ENST00000553878.1 ENST00000557530.1 |
CKB |
creatine kinase, brain |
chr6_-_160148356 | 1.11 |
ENST00000401980.3 ENST00000545162.1 |
SOD2 |
superoxide dismutase 2, mitochondrial |
chr8_-_145028013 | 1.10 |
ENST00000354958.2 |
PLEC |
plectin |
chr12_-_52845910 | 1.10 |
ENST00000252252.3 |
KRT6B |
keratin 6B |
chr8_-_145652336 | 1.10 |
ENST00000529182.1 ENST00000526054.1 |
VPS28 |
vacuolar protein sorting 28 homolog (S. cerevisiae) |
chr22_+_23264766 | 1.10 |
ENST00000390331.2 |
IGLC7 |
immunoglobulin lambda constant 7 |
chr17_-_39928501 | 1.09 |
ENST00000420370.1 |
JUP |
junction plakoglobin |
chr16_+_28874345 | 1.09 |
ENST00000566209.1 |
SH2B1 |
SH2B adaptor protein 1 |
chr18_+_68002675 | 1.08 |
ENST00000584919.1 |
RP11-41O4.1 |
Uncharacterized protein |
chr19_-_51512804 | 1.08 |
ENST00000594211.1 ENST00000376832.4 |
KLK9 |
kallikrein-related peptidase 9 |
chr11_-_69867159 | 1.07 |
ENST00000528507.1 |
RP11-626H12.2 |
RP11-626H12.2 |
chr17_-_76123101 | 1.07 |
ENST00000392467.3 |
TMC6 |
transmembrane channel-like 6 |
chr16_-_67970990 | 1.07 |
ENST00000358514.4 |
PSMB10 |
proteasome (prosome, macropain) subunit, beta type, 10 |
chr16_-_18441131 | 1.06 |
ENST00000339303.5 |
NPIPA8 |
nuclear pore complex interacting protein family, member A8 |
chr19_+_35630926 | 1.06 |
ENST00000588081.1 ENST00000589121.1 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr19_-_51289436 | 1.06 |
ENST00000562076.1 |
CTD-2568A17.1 |
CTD-2568A17.1 |
chr8_-_145018905 | 1.05 |
ENST00000398774.2 |
PLEC |
plectin |
chr8_+_142402089 | 1.05 |
ENST00000521578.1 ENST00000520105.1 ENST00000523147.1 |
PTP4A3 |
protein tyrosine phosphatase type IVA, member 3 |
chr14_-_101295407 | 1.03 |
ENST00000596284.1 |
AL117190.2 |
AL117190.2 |
chr12_+_22778291 | 1.03 |
ENST00000545979.1 |
ETNK1 |
ethanolamine kinase 1 |
chr12_-_53242770 | 1.02 |
ENST00000304620.4 ENST00000547110.1 |
KRT78 |
keratin 78 |
chr17_-_73285293 | 1.02 |
ENST00000582778.1 ENST00000581988.1 ENST00000579207.1 ENST00000583332.1 ENST00000416858.2 ENST00000442286.2 ENST00000580151.1 ENST00000580994.1 ENST00000584438.1 ENST00000320362.3 ENST00000580273.1 |
SLC25A19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
chr22_-_39636914 | 1.02 |
ENST00000381551.4 |
PDGFB |
platelet-derived growth factor beta polypeptide |
chr11_-_104480019 | 1.02 |
ENST00000536529.1 ENST00000545630.1 ENST00000538641.1 |
RP11-886D15.1 |
RP11-886D15.1 |
chr18_-_19748379 | 1.02 |
ENST00000579431.1 |
GATA6-AS1 |
GATA6 antisense RNA 1 (head to head) |
chr11_+_60691924 | 1.02 |
ENST00000544065.1 ENST00000453848.2 ENST00000005286.4 |
TMEM132A |
transmembrane protein 132A |
chr14_+_95078714 | 1.01 |
ENST00000393078.3 ENST00000393080.4 ENST00000467132.1 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr20_+_44462749 | 1.01 |
ENST00000372541.1 |
SNX21 |
sorting nexin family member 21 |
chr7_-_56160625 | 1.01 |
ENST00000446428.1 ENST00000432123.1 ENST00000452681.2 ENST00000537360.1 |
PHKG1 |
phosphorylase kinase, gamma 1 (muscle) |
chr17_-_2615031 | 1.01 |
ENST00000576885.1 ENST00000574426.2 |
CLUH |
clustered mitochondria (cluA/CLU1) homolog |
chr16_-_69448 | 1.00 |
ENST00000326592.9 |
WASH4P |
WAS protein family homolog 4 pseudogene |
chr17_-_2318731 | 0.99 |
ENST00000609667.1 |
AC006435.1 |
Uncharacterized protein |
chr16_-_88772670 | 0.99 |
ENST00000562544.1 |
RNF166 |
ring finger protein 166 |
chr14_+_105935396 | 0.98 |
ENST00000494981.1 |
MTA1 |
metastasis associated 1 |
chr8_+_61822605 | 0.98 |
ENST00000526936.1 |
AC022182.1 |
AC022182.1 |
chr17_-_4689649 | 0.97 |
ENST00000441199.2 ENST00000416307.2 |
VMO1 |
vitelline membrane outer layer 1 homolog (chicken) |
chr1_+_32666188 | 0.97 |
ENST00000421922.2 |
CCDC28B |
coiled-coil domain containing 28B |
chr7_-_73153161 | 0.97 |
ENST00000395147.4 |
ABHD11 |
abhydrolase domain containing 11 |
chr19_-_17516449 | 0.97 |
ENST00000252593.6 |
BST2 |
bone marrow stromal cell antigen 2 |
chr19_+_45394477 | 0.97 |
ENST00000252487.5 ENST00000405636.2 ENST00000592434.1 ENST00000426677.2 ENST00000589649.1 |
TOMM40 |
translocase of outer mitochondrial membrane 40 homolog (yeast) |
chr19_+_50919056 | 0.96 |
ENST00000599632.1 |
CTD-2545M3.6 |
CTD-2545M3.6 |
chr1_+_2407754 | 0.96 |
ENST00000419816.2 ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2 |
phospholipase C, eta 2 |
chr9_-_139268068 | 0.96 |
ENST00000371734.3 ENST00000371732.5 ENST00000315908.7 |
CARD9 |
caspase recruitment domain family, member 9 |
chr16_+_3115323 | 0.96 |
ENST00000531965.1 ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32 |
interleukin 32 |
chr5_-_150466692 | 0.95 |
ENST00000315050.7 ENST00000523338.1 ENST00000522100.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr4_+_668348 | 0.95 |
ENST00000511290.1 |
MYL5 |
myosin, light chain 5, regulatory |
chr6_+_2245982 | 0.95 |
ENST00000530346.1 ENST00000524770.1 ENST00000532124.1 ENST00000531092.1 ENST00000456943.2 ENST00000529893.1 |
GMDS-AS1 |
GMDS antisense RNA 1 (head to head) |
chr5_-_159739483 | 0.94 |
ENST00000519673.1 ENST00000541762.1 |
CCNJL |
cyclin J-like |
chr8_-_72756667 | 0.94 |
ENST00000325509.4 |
MSC |
musculin |
chr9_-_21368075 | 0.94 |
ENST00000449498.1 |
IFNA13 |
interferon, alpha 13 |
chr11_-_18270182 | 0.93 |
ENST00000528349.1 ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2 |
serum amyloid A2 |
chr2_+_220491973 | 0.93 |
ENST00000358055.3 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
chr19_+_535835 | 0.93 |
ENST00000607527.1 ENST00000606065.1 |
CDC34 |
cell division cycle 34 |
chr5_+_159656437 | 0.93 |
ENST00000402432.3 |
FABP6 |
fatty acid binding protein 6, ileal |
chr11_+_65686952 | 0.93 |
ENST00000527119.1 |
DRAP1 |
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr22_+_37959647 | 0.92 |
ENST00000415670.1 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
chr5_-_162887054 | 0.92 |
ENST00000517501.1 |
NUDCD2 |
NudC domain containing 2 |
chr5_-_90610200 | 0.92 |
ENST00000511918.1 ENST00000513626.1 ENST00000607854.1 |
LUCAT1 RP11-213H15.4 |
lung cancer associated transcript 1 (non-protein coding) RP11-213H15.4 |
chr7_-_105926058 | 0.92 |
ENST00000417537.1 |
NAMPT |
nicotinamide phosphoribosyltransferase |
chr1_-_12679171 | 0.92 |
ENST00000606790.1 |
RP11-474O21.5 |
RP11-474O21.5 |
chr17_-_80009209 | 0.92 |
ENST00000429557.3 ENST00000578356.1 |
RFNG |
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr11_-_45939374 | 0.91 |
ENST00000533151.1 ENST00000241041.3 |
PEX16 |
peroxisomal biogenesis factor 16 |
chr16_+_30194916 | 0.91 |
ENST00000570045.1 ENST00000565497.1 ENST00000570244.1 |
CORO1A |
coronin, actin binding protein, 1A |
chr1_-_152539248 | 0.90 |
ENST00000368789.1 |
LCE3E |
late cornified envelope 3E |
chr11_-_73687997 | 0.90 |
ENST00000545212.1 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
chr17_+_48351785 | 0.90 |
ENST00000507382.1 |
TMEM92 |
transmembrane protein 92 |
chr16_+_3115611 | 0.89 |
ENST00000530890.1 ENST00000444393.3 ENST00000533097.2 ENST00000008180.9 ENST00000396890.2 ENST00000525228.1 ENST00000548652.1 ENST00000525377.2 ENST00000530538.2 ENST00000549213.1 ENST00000552936.1 ENST00000548476.1 ENST00000552664.1 ENST00000552356.1 ENST00000551513.1 ENST00000382213.3 ENST00000548246.1 |
IL32 |
interleukin 32 |
chr17_-_79792909 | 0.89 |
ENST00000330261.4 ENST00000570394.1 |
PPP1R27 |
protein phosphatase 1, regulatory subunit 27 |
chr12_+_132413765 | 0.89 |
ENST00000376649.3 ENST00000322060.5 |
PUS1 |
pseudouridylate synthase 1 |
chr22_+_50624323 | 0.89 |
ENST00000380909.4 ENST00000303434.4 |
TRABD |
TraB domain containing |
chr16_+_4666475 | 0.89 |
ENST00000591895.1 |
MGRN1 |
mahogunin ring finger 1, E3 ubiquitin protein ligase |
chr16_+_3115378 | 0.89 |
ENST00000529550.1 ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32 |
interleukin 32 |
chr6_-_133055896 | 0.89 |
ENST00000367927.5 ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3 |
vanin 3 |
chr1_-_205290865 | 0.89 |
ENST00000367157.3 |
NUAK2 |
NUAK family, SNF1-like kinase, 2 |
chr12_-_53207842 | 0.88 |
ENST00000458244.2 |
KRT4 |
keratin 4 |
chr16_+_67233007 | 0.88 |
ENST00000360833.1 ENST00000393997.2 |
ELMO3 |
engulfment and cell motility 3 |
chr17_-_72864739 | 0.88 |
ENST00000579893.1 ENST00000544854.1 |
FDXR |
ferredoxin reductase |
chr16_-_2770216 | 0.87 |
ENST00000302641.3 |
PRSS27 |
protease, serine 27 |
chr22_-_50970506 | 0.87 |
ENST00000428989.2 ENST00000403326.1 |
ODF3B |
outer dense fiber of sperm tails 3B |
chr7_+_76139741 | 0.87 |
ENST00000334348.3 ENST00000419923.2 ENST00000448265.3 ENST00000443097.2 |
UPK3B |
uroplakin 3B |
chr6_+_29691198 | 0.87 |
ENST00000440587.2 ENST00000434407.2 |
HLA-F |
major histocompatibility complex, class I, F |
chr20_-_36794902 | 0.86 |
ENST00000373403.3 |
TGM2 |
transglutaminase 2 |
chr2_+_220492116 | 0.86 |
ENST00000373760.2 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
chr11_-_60719213 | 0.86 |
ENST00000227880.3 |
SLC15A3 |
solute carrier family 15 (oligopeptide transporter), member 3 |
chr9_-_136344237 | 0.85 |
ENST00000432868.1 ENST00000371899.4 |
SLC2A6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr20_+_61904137 | 0.85 |
ENST00000370283.4 ENST00000523114.1 ENST00000547204.1 ENST00000549047.1 ENST00000523460.1 ENST00000519604.1 ENST00000519273.2 ENST00000370275.4 |
ARFGAP1 |
ADP-ribosylation factor GTPase activating protein 1 |
chr17_+_19282064 | 0.85 |
ENST00000603493.1 |
MAPK7 |
mitogen-activated protein kinase 7 |
chr19_+_6464502 | 0.85 |
ENST00000308243.7 |
CRB3 |
crumbs homolog 3 (Drosophila) |
chr8_+_145734433 | 0.85 |
ENST00000301327.4 |
MFSD3 |
major facilitator superfamily domain containing 3 |
chr14_-_69350920 | 0.84 |
ENST00000553290.1 |
ACTN1 |
actinin, alpha 1 |
chr22_+_30163340 | 0.84 |
ENST00000330029.6 ENST00000401406.3 |
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
chr22_-_21905120 | 0.84 |
ENST00000331505.5 |
RIMBP3C |
RIMS binding protein 3C |
chr19_+_46531127 | 0.84 |
ENST00000601033.1 |
CTC-344H19.4 |
CTC-344H19.4 |
chr6_-_160114260 | 0.84 |
ENST00000367054.2 ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2 |
superoxide dismutase 2, mitochondrial |
chr9_-_140142222 | 0.84 |
ENST00000344774.4 ENST00000388932.2 |
FAM166A |
family with sequence similarity 166, member A |
chr22_+_24999114 | 0.84 |
ENST00000412658.1 ENST00000445029.1 ENST00000419133.1 ENST00000400382.1 ENST00000438643.2 ENST00000452551.1 ENST00000400383.1 ENST00000412898.1 ENST00000400380.1 ENST00000455483.1 ENST00000430289.1 |
GGT1 |
gamma-glutamyltransferase 1 |
chr11_-_45939565 | 0.84 |
ENST00000525192.1 ENST00000378750.5 |
PEX16 |
peroxisomal biogenesis factor 16 |
chrX_+_115567767 | 0.83 |
ENST00000371900.4 |
SLC6A14 |
solute carrier family 6 (amino acid transporter), member 14 |
chr1_+_15479054 | 0.83 |
ENST00000376014.3 ENST00000451326.2 |
TMEM51 |
transmembrane protein 51 |
chr15_+_91418918 | 0.83 |
ENST00000560824.1 |
FURIN |
furin (paired basic amino acid cleaving enzyme) |
chr16_+_30194118 | 0.82 |
ENST00000563778.1 |
CORO1A |
coronin, actin binding protein, 1A |
chr17_-_40264692 | 0.82 |
ENST00000591220.1 ENST00000251642.3 |
DHX58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr17_-_19265855 | 0.82 |
ENST00000440841.1 ENST00000395615.1 ENST00000461069.2 |
B9D1 |
B9 protein domain 1 |
chr11_+_67798363 | 0.81 |
ENST00000525628.1 |
NDUFS8 |
NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) |
chr12_+_6494285 | 0.81 |
ENST00000541102.1 |
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr1_-_11907829 | 0.81 |
ENST00000376480.3 |
NPPA |
natriuretic peptide A |
chr14_-_21492251 | 0.81 |
ENST00000554398.1 |
NDRG2 |
NDRG family member 2 |
chr11_-_615570 | 0.81 |
ENST00000525445.1 ENST00000348655.6 ENST00000397566.1 |
IRF7 |
interferon regulatory factor 7 |
chr15_-_64338521 | 0.80 |
ENST00000457488.1 ENST00000558069.1 |
DAPK2 |
death-associated protein kinase 2 |
chr6_-_160147925 | 0.80 |
ENST00000535561.1 |
SOD2 |
superoxide dismutase 2, mitochondrial |
chr19_-_12708113 | 0.80 |
ENST00000440366.1 |
ZNF490 |
zinc finger protein 490 |
chr19_-_1168936 | 0.80 |
ENST00000587655.1 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
chr6_-_72129806 | 0.80 |
ENST00000413945.1 ENST00000602878.1 ENST00000436803.1 ENST00000421704.1 ENST00000441570.1 |
LINC00472 |
long intergenic non-protein coding RNA 472 |
chr8_-_145752390 | 0.80 |
ENST00000529415.2 ENST00000533758.1 |
LRRC24 |
leucine rich repeat containing 24 |
chr1_+_15272271 | 0.80 |
ENST00000400797.3 |
KAZN |
kazrin, periplakin interacting protein |
chr19_-_14682838 | 0.80 |
ENST00000215565.2 |
NDUFB7 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa |
chr10_+_91092241 | 0.80 |
ENST00000371811.4 |
IFIT3 |
interferon-induced protein with tetratricopeptide repeats 3 |
chr11_+_67033881 | 0.80 |
ENST00000308595.5 ENST00000526285.1 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
chr17_-_18266818 | 0.79 |
ENST00000583780.1 |
SHMT1 |
serine hydroxymethyltransferase 1 (soluble) |
chr7_-_45960850 | 0.79 |
ENST00000381083.4 ENST00000381086.5 ENST00000275521.6 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
chr11_-_795400 | 0.79 |
ENST00000526152.1 ENST00000456706.2 ENST00000528936.1 |
SLC25A22 |
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
chr2_+_220495800 | 0.79 |
ENST00000413743.1 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
chr1_+_31885963 | 0.79 |
ENST00000373709.3 |
SERINC2 |
serine incorporator 2 |
chr9_-_139839064 | 0.78 |
ENST00000325285.3 ENST00000428398.1 |
FBXW5 |
F-box and WD repeat domain containing 5 |
chr19_+_10381769 | 0.78 |
ENST00000423829.2 ENST00000588645.1 |
ICAM1 |
intercellular adhesion molecule 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.0 | 3.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.0 | 2.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.9 | 2.8 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 2.4 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.8 | 3.9 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.7 | 3.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.7 | 1.4 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.7 | 3.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.6 | 1.9 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.6 | 1.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.6 | 1.9 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.6 | 1.8 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.5 | 1.6 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.5 | 2.5 | GO:0032796 | uropod organization(GO:0032796) |
0.5 | 1.5 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.5 | 2.0 | GO:0090678 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.5 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.5 | 1.4 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.5 | 1.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.4 | 2.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.4 | 1.3 | GO:0018013 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.4 | 1.3 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.4 | 0.4 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.4 | 0.4 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.4 | 1.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 0.4 | GO:0051604 | protein maturation(GO:0051604) |
0.4 | 1.4 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.4 | 1.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 2.4 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.3 | 0.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.3 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.3 | 1.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.9 | GO:1905033 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.3 | 0.6 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.3 | 1.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 1.2 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 1.8 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.3 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 0.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 0.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.3 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 0.8 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.3 | 2.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.3 | 1.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.3 | 0.8 | GO:0090291 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
0.3 | 0.8 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.3 | 1.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.8 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.3 | 0.8 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.3 | 2.1 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.3 | 0.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.3 | 1.0 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 0.8 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.2 | 1.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.7 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.5 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.2 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 2.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.7 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.2 | 0.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.2 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.2 | 2.1 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 1.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 0.7 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.2 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 1.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 2.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.7 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.2 | 1.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.4 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.2 | 1.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.9 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.2 | 2.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.6 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 1.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 2.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.4 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.2 | 1.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.6 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.2 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 0.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.2 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 1.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.8 | GO:0044211 | CTP salvage(GO:0044211) |
0.2 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.6 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.2 | 0.4 | GO:0051592 | response to calcium ion(GO:0051592) |
0.2 | 0.7 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 2.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 1.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 0.7 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 0.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 1.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 1.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 1.1 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 1.9 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 2.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 0.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 0.2 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 1.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.5 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 0.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.5 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.2 | 0.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 1.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.2 | 2.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.8 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.5 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 0.5 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.2 | 1.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.2 | 0.9 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 2.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.9 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.6 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 3.8 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 5.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.4 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 1.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 1.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.1 | 0.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.3 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 1.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 2.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 1.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 1.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.5 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.3 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.6 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 1.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 0.5 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 4.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.1 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 10.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.1 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.1 | 0.4 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.1 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.6 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.1 | 0.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 2.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.9 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.1 | 2.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0009447 | putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 0.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.1 | 0.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.1 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 1.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.3 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.1 | GO:1903208 | positive regulation of mast cell cytokine production(GO:0032765) neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.6 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.1 | GO:0060541 | respiratory system development(GO:0060541) |
0.1 | 1.3 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 1.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 1.0 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.1 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.3 | GO:0051794 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
0.1 | 0.7 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.4 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 1.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 1.2 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.1 | 1.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 5.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.6 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 0.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 2.0 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.9 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.7 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.3 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.3 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.1 | 0.4 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.1 | 0.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 2.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.2 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 1.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:2000592 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.4 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.2 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 1.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.2 | GO:1904044 | response to aldosterone(GO:1904044) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0100012 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.1 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 4.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.1 | 0.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.1 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 1.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 1.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.2 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.3 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 2.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.3 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.8 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.1 | 0.4 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.1 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 1.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.8 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.4 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.1 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.1 | 0.2 | GO:0072708 | response to sorbitol(GO:0072708) |
0.1 | 0.4 | GO:0036017 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
0.1 | 0.1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.2 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.1 | 0.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.2 | GO:0039521 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.1 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.1 | GO:0033122 | regulation of cyclic nucleotide catabolic process(GO:0030805) negative regulation of cyclic nucleotide catabolic process(GO:0030806) regulation of cAMP catabolic process(GO:0030820) negative regulation of cAMP catabolic process(GO:0030821) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 1.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 0.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.3 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 1.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.5 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 1.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 2.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.1 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
0.1 | 0.1 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.1 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.1 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0072025 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.1 | 0.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.1 | 0.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 0.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 2.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 1.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.2 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.9 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.2 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 1.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.3 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 1.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.3 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.1 | 0.3 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
0.1 | 1.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.5 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 1.0 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 4.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.2 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.5 | GO:0098659 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.0 | 0.1 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 1.0 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 1.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.0 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.1 | GO:0071221 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.0 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.2 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.0 | 5.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.0 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 1.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 2.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.2 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.2 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 0.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.2 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.2 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.0 | 0.1 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.0 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.4 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 1.1 | GO:0006735 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.4 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.0 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
0.0 | 1.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.2 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.0 | 0.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.0 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.2 | GO:1902692 | negative regulation of neuroblast proliferation(GO:0007406) regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.2 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 1.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.0 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.0 | 0.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.7 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.2 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.0 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.0 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 2.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.1 | GO:0001889 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.4 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.0 | 0.1 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0071941 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.1 | GO:0060319 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil differentiation(GO:0030222) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) |
0.0 | 0.6 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.2 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.0 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.3 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 3.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.0 | 0.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.0 | 1.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.0 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.2 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.8 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.7 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.0 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) regulation of amacrine cell differentiation(GO:1902869) |
0.0 | 0.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 0.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.7 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.0 | 0.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.0 | 0.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) positive regulation of oocyte maturation(GO:1900195) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.0 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.0 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.0 | 0.0 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 1.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.0 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.0 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.0 | 0.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 2.2 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.2 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.1 | GO:0003188 | heart valve formation(GO:0003188) |
0.0 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 2.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 1.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.0 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0070977 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.1 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0048807 | ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.2 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0019075 | virus maturation(GO:0019075) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.0 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.3 | GO:0015758 | glucose transport(GO:0015758) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.1 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0030902 | hindbrain development(GO:0030902) |
0.0 | 0.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0072014 | proximal tubule development(GO:0072014) |
0.0 | 0.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) left/right axis specification(GO:0070986) |
0.0 | 0.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.4 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.0 | 0.0 | GO:0006538 | glutamate catabolic process(GO:0006538) glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.0 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.1 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.0 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0072511 | divalent inorganic cation transport(GO:0072511) |
0.0 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0046098 | guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 1.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.0 | 0.1 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.0 | 0.0 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 1.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.4 | 1.7 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.3 | 2.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 2.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 0.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 1.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.1 | GO:0002133 | polycystin complex(GO:0002133) |
0.2 | 0.6 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.2 | 2.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 2.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.7 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.2 | 0.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.8 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 1.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 3.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 2.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 2.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.3 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 0.4 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.7 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 7.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.6 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0036024 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 3.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 3.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 1.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.1 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.7 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 3.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.1 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 2.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0060171 | myosin I complex(GO:0045160) stereocilium membrane(GO:0060171) |
0.1 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 2.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 3.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 2.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 9.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.2 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 1.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 3.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 2.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.0 | 4.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 1.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 4.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.0 | 3.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 1.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 2.5 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 2.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 5.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 2.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 1.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0044456 | synapse part(GO:0044456) |
0.0 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) symmetric synapse(GO:0032280) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 2.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 2.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.8 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 2.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 1.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 2.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 4.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 3.0 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 4.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 21.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 1.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.0 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 1.2 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.0 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.8 | 2.4 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.6 | 1.7 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.5 | 1.5 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.5 | 5.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.5 | 1.9 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 1.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.4 | 0.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.4 | 1.7 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.4 | 1.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.4 | 1.7 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 4.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 1.2 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.4 | 1.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.4 | 1.2 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.4 | 8.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 1.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 1.0 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.3 | 0.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.3 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 3.0 | GO:0005497 | androgen binding(GO:0005497) |
0.3 | 1.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.3 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 2.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.9 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.3 | 0.9 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.3 | 0.9 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.3 | 2.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.3 | 1.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.3 | 1.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.3 | 1.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.5 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 1.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 0.7 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 1.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 0.7 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 1.6 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 0.7 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 1.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.2 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.6 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 1.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 0.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.2 | 1.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.2 | 0.6 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.2 | 0.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 0.7 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 1.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.2 | 0.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.5 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.2 | 0.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 1.2 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 0.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.2 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 0.5 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.2 | 0.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 0.5 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.2 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.7 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 2.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 3.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 1.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.1 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.1 | 0.9 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.1 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.4 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 2.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.4 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 2.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.3 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 3.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 6.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.4 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.1 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 3.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.4 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.1 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 3.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.5 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.7 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 2.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 2.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.5 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 2.6 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.4 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.1 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.2 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 3.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 14.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 0.2 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 1.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 2.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.1 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 1.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 1.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 2.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 0.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.0 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 8.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.0 | 0.8 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.2 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.0 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.0 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0001026 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0050308 | phosphofructokinase activity(GO:0008443) carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 6.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.4 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0099583 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.5 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.1 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.0 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 1.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 2.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.4 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.0 | 5.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:1990175 | EH domain binding(GO:1990175) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.0 | 0.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 3.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 3.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 1.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.8 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 2.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.5 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 2.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.0 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 6.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 6.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0052835 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 8.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.0 | 0.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 1.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0044548 | S100 protein binding(GO:0044548) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 8.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 4.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 5.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 3.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 3.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 5.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 19.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 2.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 2.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 2.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 2.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 2.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 22.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 7.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 7.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 2.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 8.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 4.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 4.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 3.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 4.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 2.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 6.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 4.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 2.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.5 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |